Montana prepares to launch closed drug formulary
Reprints
Montana is preparing to adopt a closed drug formulary for injured workers, according to an announcement published on the webpage for the Work Loss Data Institute L.L.C., which is helping to bring a formulary there.
Following a presentation by the Montana Drug Formulary Committee and a unanimous vote by the Labor-Management Advisory Council on Tuesday, the state will be using the institute’s evidence-based Official Disabilities Guidelines formulary, which was used in Texas, Oklahoma, Arizona and Tennessee, according to a press announcement posted by the Encinitas, California-based institute. ODG is a product that provides clinical guidelines and analytical tools specifically designed to improve and benchmark return-to-work performance and facilitate quality care.
“With a focus on employee health and return-to-work, the MT Drug Formulary Committee stated their two highest goals with regard to a formulary adoption are to reduce the number of dangerous prescriptions, and to improve patient outcomes,” the press announcement stated.
The state will commence with project planning, with no dates yet announced for rulemaking, according to the press announcement.
“The Montana Labor-Management Advisory Council (LMAC) and Drug Formulary committee should be applauded in completing a thorough analysis of available formularies, selecting ODG based on its proven track record, best-in-class evidence based methodology, widespread use, and robust, actionable customer experience, " said Phil LeFevre, managing director at ODG, in a press statement. "We look forward to working with stakeholders on rule-making and implementation, bringing a proven model of responsible prescribing practices to Big Sky Country."
Read Next
-
Pennsylvania drug formulary bill progresses
Pennsylvania lawmakers will meet again Tuesday to examine amendments to a bill proposing to create a workers compensation drug formulary.
Related Stories
-
-
Opioid weaning problems remain in California comp formulary but no delay expected
-
Arkansas gears up for comp drug formulary that limits opioids
